Literature DB >> 7961019

T1 nasopharyngeal carcinoma: the effect of waiting time on tumor control.

A W Lee1, D K Chan, J F Fowler, Y F Poon, S C Law, W Foo, S K O, S Y Tung, F K Cheung, J H Ho.   

Abstract

PURPOSE: To study the effect of unperturbed tumor growth on the control of nasopharyngeal carcinoma. METHODS AND MATERIALS: This is a retrospective analysis of 290 patients with T1N0-3M0 disease (Ho's classification) treated by the same technique and dose schedule to the nasopharyngeal region. The median interval from diagnosis to commencement of irradiation was 26 days (range: 8-68 days). Cox proportional hazards analyses were performed to study the independent effect of waiting time on the probability of failure at various sites. Actuarial failure-free survival of patients with delay < 22 days, 22-28 days and > 28 days were also compared to illustrate the clinical observation.
RESULTS: Both tests showed that waiting time had no significant impact on local failure: The N-stage stratified hazard ratio was 0.985 per day, and the 10-year local failure-free survival for the three groups was 76%, 80%, and 82%, respectively. A similar result was obtained for nodal control in patients with our scheduled neck irradiation. Although the p value of all tests failed to reach statistical significance, the N-stage stratified hazard ratio for distant failure was 1.020 per day, and the corresponding metastasis-free survival in patients with N2-3 disease was 70%, 65%, and 52%, respectively. For node-negative patients without elective neck irradiation, the hazard ratio was 1.019 per day, with the corresponding regional failure-free rates at 57%, 62%, and 33%, respectively.
CONCLUSION: Delay in initiation of treatment to the primary target (within the range observed) did not affect the control rate at irradiated sites, but there was a trend (though statistically insignificant) towards increase in failures at untreated sites that were clinically too serious to be ignored.

Entities:  

Mesh:

Year:  1994        PMID: 7961019     DOI: 10.1016/0360-3016(94)90317-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy.

Authors:  Georges Noel; Aymeri Huchet; Loic Feuvret; Jean Philippe Maire; Pierre Verrelle; Emilie Le Rhun; Maud Aumont; François Thillays; Marie Pierre Sunyach; Chantal Henzen; Fernand Missohou; Renaud de Crevoisier; Pierre Yves Bondiau; Philippe Collin; Xavier Durando; Gilles Truc; Christine Kerr; Valérie Bernier; Jean-Baptiste Clavier; David Atlani; Anne D'Hombres; Sandrine Vinchon-Petit; Jean Léon Lagrange; Luc Taillandier
Journal:  J Neurooncol       Date:  2012-06-02       Impact factor: 4.130

2.  The effect of time between diagnosis and initiation of treatment on outcomes in patients with head and neck squamous cell carcinoma.

Authors:  Luke H DeGraaff; Alexis J Platek; Austin J Iovoli; Kimberly E Wooten; Hassan Arshad; Vishal Gupta; Ryan P McSpadden; Moni Abraham Kuriakose; Wesley L Hicks; Mary E Platek; Anurag K Singh
Journal:  Oral Oncol       Date:  2019-07-30       Impact factor: 5.337

3.  The impact of the time to start radiation therapy on overall survival in newly diagnosed glioblastoma.

Authors:  Vanessa Montes Santos; Gustavo Nader Marta; Marcella Coelho Mesquita; Rossana Veronica Mendoza Lopez; Edla Renata Cavalcante; Olavo Feher
Journal:  J Neurooncol       Date:  2019-03-08       Impact factor: 4.130

4.  Impact of Time Factors on Outcome in Patients with Head and Neck Cancer Treated with Definitive Radio(Chemo)Therapy.

Authors:  Sören Dahlke; Diana Steinmann; Hans Christiansen; Martin Durisin; Andre Eckardt; Gerd Wegener; Michael Bremer; Andreas Meyer
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

5.  Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database.

Authors:  Deborah T Blumenthal; Minhee Won; Minesh P Mehta; Walter J Curran; Luis Souhami; Jeff M Michalski; C Leland Rogers; Benjamin W Corn
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

6.  How Long Are Cancer Patients Waiting for Oncological Therapy in Poland?

Authors:  Karolina Osowiecka; Monika Rucinska; Jacek J Nowakowski; Sergiusz Nawrocki
Journal:  Int J Environ Res Public Health       Date:  2018-03-23       Impact factor: 3.390

7.  Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma.

Authors:  Sebastian Adeberg; Tilman Bostel; Semi Harrabi; Denise Bernhardt; Thomas Welzel; Wolfgang Wick; Juergen Debus; Stephanie E Combs
Journal:  BMC Cancer       Date:  2015-07-30       Impact factor: 4.430

8.  The impact of time factors on overall survival in patients with nasopharyngeal carcinoma: a population-based study.

Authors:  Po-Chun Chen; Wen-Shan Liu; Wei-Lun Huang; Cheng-Jung Wu; Ching-Chieh Yang; Ching-Chih Lee
Journal:  Radiat Oncol       Date:  2016-04-27       Impact factor: 3.481

9.  Prognostic value of wait time in nasopharyngeal carcinoma treated with intensity modulated radiotherapy: a propensity matched analysis.

Authors:  Yu-Pei Chen; Yan-Ping Mao; Wen-Na Zhang; Lei Chen; Ling-Long Tang; Wen-Fei Li; Xu Liu; Guan-Qun Zhou; Rui Guo; Ying Sun; Tie-Bang Kang; Mu-Sheng Zeng; Jun Ma
Journal:  Oncotarget       Date:  2016-03-22

10.  Impact of delays in radiotherapy of head and neck cancer on outcome.

Authors:  Barbara Žumer; Maja Pohar Perme; Simona Jereb; Primož Strojan
Journal:  Radiat Oncol       Date:  2020-08-20       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.